Found 80 articles for: "skin cancer"
Use of Bovine Xenografts for Nasal Defects After Mohs Micrographic Surgery
January 2025 | Volume 24 | Issue 1 | Editorial | 96 | Copyright © January 2025
Background: Nasal defects after skin cancer excision can often be healed by second intention in certain circumstances.Objective: We aim to demonstra...
Read MoreNovel Methods in Acne Treatment and Skin Care: A Review
December 2024 | Volume 23 | Issue 12 | Original Article | e181 | Copyright © December 2024
Background: Acne skin care aims to reduce the stratum corneum layer, normalization of sebum secretion, and mitigation of purulent lesions. Antibiotics, such as macrolides, clinda...
Read MoreMohs Micrographic Surgery for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma: An Outcomes Study
December 2024 | Volume 23 | Issue 12 | Original Article | 1094 | Copyright © December 2024
Background: Lentigo maligna (LM), a type of melanoma in situ (MIS), usually develops on sun-damaged skin in the elderly. If left untreated, it may advance to the point of dermal ...
Read MoreCost Analysis of Sunscreens Targeted Towards Skin of Color
November 2024 | Volume 23 | Issue 11 | Features | e181 | Copyright © November 2024
Skin cancer most commonly affects fair-skinned individuals1; however, it can appear in individuals of all skin tones. Photoprotective behaviors such as applying sunscreen should be pra...
Read MoreAdvances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel
September 2024 | Volume 23 | Issue 9 | Original Article | 774 | Copyright © September 2024
Background: Cutaneous melanoma (CM) is associated with a higher mortality rate than most other skin cancers. The purpose of this expert consensus panel was to review the publishe...
Read MoreUtility of Artificial Intelligence in Patient Education: An Appraisal of Mohs Surgery Information Generated by ChatGPT-3.5 and ChatGPT-4
May 2024 | Volume 23 | Issue 5 | Editorials | e139 | Copyright © May 2024
The Use of Natural Therapies in Patients With Skin Cancer: A Scoping Review
May 2024 | Volume 23 | Issue 5 | Original Article | 322 | Copyright © May 2024
Complementary and alternative medicine (CAM) use has become a field of growing interest in dermatology. However, the prevalence of CAM use is difficult to quantify as it varies based on many fact...
Read MorePostinflammatory Hyperpigmentation Following Mohs Micrographic Surgery: An Observational Study
May 2024 | Volume 23 | Issue 5 | Original Article | 316 | Copyright © May 2024
Importance: Functional and cosmetic outcomes following Mohs micrographic surgery (MMS) are poorly studied in individuals with skin of color (SOC). Postinflammatory hyperpigmentat...
Read MoreUnderstanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma
May 2024 | Volume 23 | Issue 5 | Original Article | 311 | Copyright © May 2024
Purpose: In this review article, we sought to elucidate how the social determinants of health, including socioeconomic status, education, neighborhood or physical environment, ac...
Read MoreInfluence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes
May 2024 | Volume 23 | Issue 5 | Original Article | 306 | Copyright © May 2024
Background: There are no guidelines on when to more strongly recommend sentinel lymph node biopsy (SLNB) for T1b melanomas.
Objective: To examine whether a...
Read MoreBeyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma Skin Cancers
May 2024 | Volume 23 | Issue 5 | Original Article | 301 | Copyright © May 2024
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (B...
Read MoreSkin Tone Representation on Patient-Facing Skin Cancer Education Websites
May 2024 | Volume 23 | Issue 5 | Editorials | e137 | Copyright © May 2024
When patients self-detect suspicious skin lesions, they often reference online photos prior to seeking medical evaluation. Online images must be available in the full spectrum of skin tones to pr...
Read MoreMetastatic Merkel Cell Carcinoma After Simultaneous Pancreas-Kidney Transplantation: Fatal Outcomes
May 2024 | Volume 23 | Issue 5 | Case Reports | 376 | Copyright © May 2024
Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous malignancy. Immunosuppression increases the risk of MCC and is associated with poor prognosis. Organ transplant recipients (OTR)...
Read MoreA Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery
May 2024 | Volume 23 | Issue 5 | Case Reports | 380 | Copyright © May 2024
Wound repair of the pretibial and forearm regions presents a challenge during dermatologic surgery as these areas are under significant tension and exhibit increased skin fragility. Various metho...
Read MoreCutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine
April 2024 | Volume 23 | Issue 4 | Case Reports | 275 | Copyright © April 2024
The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients
February 2024 | Volume 23 | Issue 2 | Original Article | 78 | Copyright © February 2024
Immune checkpoint inhibitors (ICI) are widely utilized for the treatment of malignant melanoma. Interestingly, gastrointestinal microbiome composition has emerged as a predictive biomarker of imm...
Read MoreIncorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreA Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
December 2023 | Volume 22 | Issue 12 | Case Reports | 1223 | Copyright © December 2023
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and musc...
Read MoreCheckpoint Inhibitor-Induced Neurotoxicity in a Case of Metastatic Melanoma
December 2023 | Volume 22 | Issue 12 | Case Reports | e25 | Copyright © December 2023
Checkpoint inhibitors (CPIs) are increasingly being used in the treatment of malignant melanoma. While showing promise in metastatic melanoma treatment, CPIs are associated with immune-related ad...
Read MoreKeratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin
May 2023 | Volume 22 | Issue 5 | Original Article | 486 | Copyright © May 2023
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
